Chaparral Labs
back to search

protein

Apolipoprotein A-II

aka Apo-AII, ApoA-II

APOA2
protein:P02652disease:adad:direction:down

Gene

APOA2

Organism

Homo sapiens(9606)

Length

100 aa

Mass

11,175 Da

AI summarysource-grounded · cited inline
claude-haiku-4-5-20251001

Apolipoprotein A-II (APOA2) is a 100-amino acid protein that plays a structural role in high-density lipoprotein (HDL) metabolism by stabilizing HDL particles through lipid association (UniProt: P02652). The protein is involved in lipid transport and metabolism pathways, with no documented Mendelian disease associations in UniProt.

APOA2 is relevant to Alzheimer's Disease pathology. Proteomics analysis of post-mortem AD brain tissue versus age-matched controls revealed significant downregulation of APOA2, with a mean log2 fold-change of −1.1 across subcellular fractions (Chaparral AD proteomics). This downregulation suggests impaired HDL-mediated lipid metabolism in AD brain, which may contribute to the neuroinflammatory and metabolic dysfunction characteristic of the disease. The consistent reduction across multiple subcellular compartments indicates a global decrease in APOA2 protein levels in AD pathology.

Generated from the curated entity record below. May contain errors — verify against source links.

Proteomics Evidence · AD

↓ Down in AD

P3

not detected

P2

not detected

S2

not detected

S3

-1.105

Mean log₂FC across detected fractions: -1.1047 (1 of 4 fractions detected)

Human post-mortem AD brain vs age-matched controls, TMT-labeled, 4 subcellular fractions (P2, P3, S2, S3), DDA proteomics.

Related Publications

Browse all →

Function

May stabilize HDL (high density lipoprotein) structure by its association with lipids, and affect the HDL metabolism

Sources

Last updated 5/8/2026, 6:31:26 AM